ArticleJGH open : an open access journal of gastroenterology and hepatology2022

A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C.

Chi-Yi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.